首页> 外国专利> management of transglutaminase - catalysed by transglutaminase proteinmodifizierung selective irreversible inhibitors

management of transglutaminase - catalysed by transglutaminase proteinmodifizierung selective irreversible inhibitors

机译:转谷氨酰胺酶修饰的不可逆抑制剂催化转谷氨酰胺酶的管理

摘要

Method for specific protein modification catalyzed by transglutaminase (TG) which is controlled by at least one selective, irreversible TG inhibitor (A). Independent claims are also included for the following: (1) (A) of formula (I); and (2) method for preparing sidechain-modified peptides, as (A), by replacing, in a peptide known to be a TG substrate, a Glu residue by a modified Glu that has a methyl ketone in the gamma -position. X : diazo, Me2S+, RCOO or RS; Xaa1 and Xaa2 : amino protecting group, amino acid (or derivative) or peptide of 2-8, preferably 6-8, amino acids (or derivatives); proviso : the compound acetyl-prolinyl-glutaminyl-prolinyl-(6-diazo-5-oxoleucinyl)leucinyl-prolinyl-phenylalaninyl-NH2 is excluded and R is not defined [Image].
机译:通过转谷氨酰胺酶(TG)催化的特定蛋白质修饰的方法,该转谷氨酰胺酶(TG)由至少一种选择性不可逆的TG抑制剂(A)控制。还包括以下方面的独立权利要求:(1)式(I)(A); (2)如(A)所述的侧链修饰肽的制备方法,其在已知为TG底物的肽中,将Glu残基置换为在γ位具有甲基酮的修饰Glu。 X:重氮,Me 2 S +,RCOO或RS; Xaa1和Xaa2:氨基保护基,氨基酸(或衍生物)或2-8,优选6-8的氨基酸(或衍生物)的肽;条件:排除了化合物乙酰基-脯氨酰基-谷氨酰胺基-脯氨酰基-(6-重氮基5-氧代油酰基)亮氨酰-脯氨酰基-苯丙氨酰基-NH2 [未定义]。

著录项

  • 公开/公告号DE502005000803D1

    专利类型

  • 公开/公告日2007-07-19

    原文格式PDF

  • 申请/专利权人 N-ZYME BIOTEC GMBH;

    申请/专利号DE20055000803T

  • 申请日2005-05-04

  • 分类号C12N9/10;C07K1/13;C07K5/00;C07K5/06;C07K5/083;C07K5/103;C07K7/06;

  • 国家 DE

  • 入库时间 2022-08-21 20:28:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号